Onyvax Ltd.
Onyvax Ltd.
http://www.onyvax.com/ Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells. Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their contacts in London, UK. Cancer Onyvax is an early-stage biotechnology company focussed on the development of cancer therapies that employ the selectivity and power of the immune system to seek and destroy tumour cells.speciality biotechnology company, has acquired all of the intellectual property relating to Onyvax-P. All further development of Onyvax's products will be conducted through VaxOnco. Onyvax is developing new cancer therapies that harness the selective power of the immune system to seek out and trial research cancer biotechnology UK immune immunotherapy antibody oncology colorectal vaccine St George's prostate vaccine
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
Google Ads
Other links at Cancer
Researches and develops novel therapeutic and diagnostic products to treat chronic debilitating diseases such as cancer, central nervous system disorders and autoimmune diseases. Based in Massachusetts. (Nasdaq: BLSI).
Category:
Develops and commercializes innovative small molecule drugs, initially for improving cancer treatments. Based in Westminster, Colorado. (Nasdaq: ALTH)
Category:
Offers products for diagnosis, imaging and treatment of tumors, especially in lung. Technologies in sputum sample and pap smear screening, certifying cell lines, inflammatory focus imaging, Cu-TCPP treatment in pre-clinical development at Albuquerque, New Mexico.
Category:
Main Category
14
100
31
5
50
7
11
40
166
20
59
76
24
75
110
142
7
8
13
30
66
Join Mailing List
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.
Top 10
Directory Statistics
Links: 1054
Categories: 36
Pagerank Statistics
Yahoo News